Delivery across the UAE: Dubai · Abu Dhabi · Sharjah · Ajman · Ras Al Khaimah · Umm Al Quwain · Fujairah

DXBTIDES / ANALYSIS DOCUMENT RECORD

Tesamorelin 20 mg

DXBTides transcription of a supplier-issued COA. This is not a new laboratory report or testing certificate issued by DXBTides.

LOT
DT-2026-03-002-K2
Batch
2026-03-002-K2
Strength
Tesamorelin 20 mg
Manufactured
Not reported
Expiry
Not reported
Source test date
24 AUG 2026
Source storage
Not reported

Analytical results reported by the source

TestReported resultMethod
Identity (LC-MS)TesamorelinAs reported
Purity (HPLC-UV)99.82%As reported
Tesamorelin content20.30 mgAs reported

Source and documentation scope

Source laboratory: FREEDOM DIAGNOSTICS · Report reference: 2608190345

This record identifies the source document and LOT; it does not confirm current stock matches or batch release. A source-vial COA does not certify a prepared pen's final purity or sterility; a separate preparation and traceability record is required.

Original document fingerprint4fbf3da9c82dfc802fdc9fdac779833ae01f0e024eb452cdbf775e6f39b0128d

For in vitro research use only; not for human or animal consumption. The QR opens this document record and does not represent laboratory accreditation.